RANKINGS
Lowest P/B — Healthcare
Price-to-Book ratio compares market value to book value. Lower may signal value.
207 companies with P/B Ratio data.
Ranked by P/B Ratio(207)
| # | Ticker | Name | Market Cap | P/B Ratio |
|---|---|---|---|---|
| 1 | GURE | $6M | 0.1 | |
| 2 | SCNI | $1M | 0.2 | |
| 3 | BON | $9M | 0.2 | |
| 4 | PMCB | $7M | 0.2 | |
| 5 | VHI | $398M | 0.3 | |
| 6 | MGX | $50M | 0.4 | |
| 7 | TLRY | $551M | 0.4 | |
| 8 | AVD | $76M | 0.4 | |
| 9 | OGEN | $3M | 0.4 | |
| 10 | SNDL | $341M | 0.4 | |
| 11 | INAB | $13M | 0.6 | |
| 12 | LITS | $32M | 0.6 | |
| 13 | COTY | $2.0B | 0.6 | |
| 14 | MOS | $7.1B | 0.6 | |
| 15 | RMTI | $22M | 0.6 | |
| 16 | QDEL | $1.2B | 0.7 | |
| 17 | AMRN | $308M | 0.7 | |
| 18 | TCRX | $67M | 0.7 | |
| 19 | TOVX | $11M | 0.7 | |
| 20 | HUN | $2.0B | 0.7 | |
| 21 | CRIS | $9M | 0.7 | |
| 22 | FMC | $1.4B | 0.7 | |
| 23 | OPK | $929M | 0.8 | |
| 24 | NL | $292M | 0.8 | |
| 25 | FLNA | $56M | 0.8 | |
| 26 | EPC | $1.3B | 0.9 | |
| 27 | CELZ | $6M | 0.9 | |
| 28 | CRON | $1.0B | 0.9 | |
| 29 | ERNA | $6M | 0.9 | |
| 30 | KRO | $743M | 1.0 | |
| 31 | NEOG | $2.1B | 1.0 | |
| 32 | CATX | $352M | 1.0 | |
| 33 | BDTX | $109M | 1.0 | |
| 34 | QNCX | $17M | 1.1 | |
| 35 | WLK | $9.7B | 1.1 | |
| 36 | SCYX | $44M | 1.1 | |
| 37 | SCL | $1.3B | 1.1 | |
| 38 | AMPH | $851M | 1.1 | |
| 39 | VYGR | $196M | 1.1 | |
| 40 | LTBR | $253M | 1.2 | |
| 41 | CE | $5.3B | 1.2 | |
| 42 | VERU | $41M | 1.2 | |
| 43 | PASG | $14M | 1.2 | |
| 44 | INVA | $1.6B | 1.2 | |
| 45 | ALGS | $39M | 1.2 | |
| 46 | DD | $17.9B | 1.3 | |
| 47 | EMN | $7.7B | 1.3 | |
| 48 | MTX | $2.2B | 1.3 | |
| 49 | TARA | $235M | 1.3 | |
| 50 | VTRS | $19.1B | 1.3 | |
| 51 | DOW | $21.9B | 1.3 | |
| 52 | FDMT | $591M | 1.3 | |
| 53 | IMUX | $199M | 1.3 | |
| 54 | SRPT | $2.0B | 1.3 | |
| 55 | INTS | $13M | 1.3 | |
| 56 | AVNT | $3.3B | 1.3 | |
| 57 | IFF | $19.2B | 1.4 | |
| 58 | OLN | $2.4B | 1.4 | |
| 59 | ALB | $14.8B | 1.5 | |
| 60 | LXU | $810M | 1.5 | |
| 61 | IOSP | $2.0B | 1.5 | |
| 62 | GPRE | $1.2B | 1.5 | |
| 63 | KLRS | $105M | 1.5 | |
| 64 | PFE | $139.5B | 1.5 | |
| 65 | IKT | $259M | 1.5 | |
| 66 | BMRA | $5M | 1.6 | |
| 67 | CYRX | $792M | 1.6 | |
| 68 | MYGN | $553M | 1.6 | |
| 69 | BIIB | $30.9B | 1.7 | |
| 70 | ACNT | $137M | 1.7 | |
| 71 | SNGX | $5M | 1.7 | |
| 72 | RCKT | $406M | 1.7 | |
| 73 | SIGA | $259M | 1.7 | |
| 74 | RXRX | $1.8B | 1.7 | |
| 75 | AVXL | $218M | 1.7 | |
| 76 | CRBU | $179M | 1.7 | |
| 77 | ALTO | $455M | 1.8 | |
| 78 | BMRN | $11.4B | 1.8 | |
| 79 | CCCC | $433M | 1.9 | |
| 80 | LYB | $18.8B | 1.9 | |
| 81 | LONA | $92M | 1.9 | |
| 82 | RIGL | $764M | 1.9 | |
| 83 | FATE | $352M | 2.0 | |
| 84 | LODE | $317M | 2.0 | |
| 85 | VIR | $1.6B | 2.0 | |
| 86 | ROG | $2.4B | 2.0 | |
| 87 | ALT | $581M | 2.0 | |
| 88 | LXFR | $460M | 2.1 | |
| 89 | ABOS | $191M | 2.2 | |
| 90 | REGN | $69.5B | 2.2 | |
| 91 | CF | $18.6B | 2.3 | |
| 92 | XFOR | $382M | 2.3 | |
| 93 | NATR | $379M | 2.3 | |
| 94 | LFVN | $78M | 2.3 | |
| 95 | IOVA | $1.8B | 2.5 | |
| 96 | INMB | $49M | 2.5 | |
| 97 | SLDB | $957M | 2.6 | |
| 98 | PALI | $328M | 2.6 | |
| 99 | CBT | $4.5B | 2.7 | |
| 100 | BEAM | $3.2B | 2.7 |
How to turn this ranking into valuation work
Start with the company page
Validate business quality, margins, capital structure, and the current valuation context before relying on a single multiple.
Then validate WACC
A cheap multiple does not guarantee a sensible discount rate. Check cost of capital before finalizing DCF assumptions.
Finish with DCF
Use the matching DCF page to test intrinsic value so multiples, discount rates, and cash-flow assumptions stay connected.
P/B Ratio Rankings in Other Sectors
Data updated daily · Source: SEC EDGAR, Polygon.io